📰 Resented News
Page 9 - Resented News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.
May 25, 2023
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, presented original data in four separate poster presentations at the ISPOR conference, providing... | May 25, 2023
May 25, 2023
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with... | May 25, 2023
May 25, 2023
AUGA group, AB presented the key principles of the new business model of the Company and its subsidiaries along with the steps for its implementation, as approved by the Company’s Board. The... | May 25, 2023
May 25, 2023
After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR /KEYNOTE-581 trial Final results will be presented at ASCO 2023... | May 25, 2023
May 25, 2023
Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held... | May 25, 2023
May 25, 2023
Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphoma Poster presentations will highlight epcoritamab in lymphoma
May 25, 2023
- Enrollment progress update from ongoing China Phase 1 trial of TERN-701 to be presented at ASCO 2023 - China Phase 1 trial completed enrollment of Cohort 5 in the Dose Escalation phase FOSTER... | May 25, 2023
May 25, 2023
Approximately 39% of patients had clinical responses after a single dose of afami-cel in Cohort 1 of the pivotal SPEARHEAD-1 trial and the median duration of response was ~12 months (CTOS 2022)Median
May 24, 2023
SRV Media, New Delhi, May 23: India is a nation with endless attractions, and our Indian photographers have the impeccable ability to bring out the best in it.
May 24, 2023
Interim data to be presented in an oral presentation by Dr. Jennifer L. Taylor-Cousar, MD, MSCS at the 2023 ECFS Annual Meeting in Vienna, Austria on Thursday, June 8, 2023 at 5:00 p.m. CET Company to... | May 24, 2023